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is* The rationale for obtaining surveillance computerized tomography (CT) scans or magnetic resonance (MR) images in 
pediatric patients with brain tumors is that early detection of recurrence may result in timely treatment and better outcome. 
The purpose of this study was to investigate the value of surveillance cranial images in a variety of common pediatric brain 
tumors managed at a tertiary care pediatric hospital.
A retrospective chart review was performed of children with astrocytoma of the cerebral hemisphere, cerebellum, optic 
chiasm/hypothalamus, or thalamus; cerebellar or supratentorial high-grade glioma; supratentorial ganglioglioma; posterior 
fossa or supratentorial primitive neuroectodermal tumor (PNET); and posterior fossa ependymoma. Data were analyzed to 
determine the frequency with which recurrences were identified on a surveillance image and how the type of image at 
which recurrence was identified related to outcome.
In 159 children, 17 of 44 recurrences were diagnosed by surveillance imaging. The percentage of recurrences identified 
by surveillance imaging was 64% for ependymoma, 50% for supratentorial PNET, 43% for optic/hypothalamic astrocy­
toma, and less than 30% for other tumors. The rate of diagnosis of recurrence per surveillance image varied from 0% to
11.8% for different tumor types. Only for ependymomas did there appear to be an improved outcome when recurrence was 
identified prior to symptoms.
Our results indicate that, using the protocols outlined in this study, surveillance imaging was not valuable in identify­
ing recurrence of cerebellar astrocytoma or supratentorial ganglioglioma during the study period, but was probably worth­
while in identifying recurrence of posterior fossa ependymoma and optic/hypothalamic astrocytoma and, possibly, medul­
loblastoma. Surveillance protocols could be made more effective by individualizing them for each type of tumor, based on 
current data on the patterns of recurrence.
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A s t a n d a r d  part of the management of pediatric brain tumors includes serial follow-up computer­ized tomography (CT) and/or magnetic resonance 
(MR) imaging of the brain. The purpose of using these 
imaging techniques is 1) to document the response to 
treatment; 2) to provide a baseline against which to judge 
future imaging, so that diagnosis of recurrence or compli­
cations of treatment can be facilitated; 3) to look for evi­
dence of recurrence when new symptoms or signs are 
present; and 4) for surveillance to detect asymptomatic 
tumor recurrence. Scheduling protocols for follow-up im­
aging, particularly those performed for surveillance (sur­
veillance images), have been proposed; these protocols 
have been based loosely on the biological characteristics 
of the different varieties of pediatric brain tumors, taking 
into account the rate of tumor growth and the patterns of 
local and metastatic recurrence.2,3
The rationale for using surveillance imaging is that it 
may identify tumor recurrence before symptoms are 
present and that such early detection may translate in­
to a better outcome for the patient. Whether surveillance 
images, obtained according to existing protocols, do di­
agnose asymptomatic recurrences and improve outcome 
in practice has been studied only for the medulloblas- 
toma/primitive neuroectodermal tumor (PNET), and the 
results have been inconclusive.1,4 The potential benefits of 
such images have to be balanced against their cost; the 
risk to the child, who may require sedation; and the nega­
tive psychological impact that may be experienced in 
some families, created by the anxiety associated with an 
upcoming imaging session. In addition, if early identifica­
tion of recurrence by surveillance imaging does not im­
prove outcome, such early identification may simply pro­
long the period of suffering for the patient and family.
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The purpose of the current study was to determine, for 
a variety of common types of pediatric brain tumors man­
aged at a tertiary care pediatric hospital, the frequency 
with which recurrences were identified by surveillance 
imaging, and whether identification of recurrence by a 
surveillance image, as opposed to one obtained to investi­
gate symptoms, resulted in an improved outcome.
Clinical Material and Methods
Patient Population
The study was performed at British Columbia’s Chil­
dren’s Hospital (BCCH), the only tertiary care pediatric 
hospital in the province of British Columbia. During the 
time covered by the study, BCCH was an active member 
of the Children’s Cancer Group (CCG) and participated in 
a number of CCG protocols for the management of pedi­
atric brain tumors.
The database of the Division of Neurosurgery at BCCH 
was searched to identify children (under 18 years of age) 
who had been diagnosed and coded as having a brain 
tumor and had been followed by the Division of Neuro­
surgery at BCCH between July 1982 and June 1994. The 
database included patients who had been treated initially 
at another hospital, in addition to those treated primarily at 
BCCH. From this population, patients were selected who 
met the following criteria: 1) patient had a histologically 
proven diagnosis of low-grade astrocytoma of the cere­
bral hemisphere, cerebellum, optic chiasm/hypothalamus, 
or thalamus; cerebellar or supratentorial high-grade glio­
ma; supratentorial ganglioglioma; posterior fossa or su­
pratentorial PNET; or posterior fossa ependymoma; 2) 
patient survived more than 1 month after surgery for biop­
sy or resection of tumor; and 3) patient’s clinical records 
contained adequate information. Patients with tumors 
primarily involving the brainstem (midbrain, pons, or me­
dulla oblongata) were excluded, as were those with in­
terventricular giant-cell astrocytomas associated with tu­
berous sclerosis and with optic gliomas involving the 
optic nerve anterior to the chiasm.
The records of patients selected were reviewed to ob­
tain information regarding the tumor’s histological char­
acteristics, tumor location, extent of resection, adjuvant 
therapy, clinical status during the follow-up period, date 
of recurrence, and the dates and results of any contrast- 
enhanced CT scan or MR image of the head obtained to 
assess tumor size. Spinal MR images were not reviewed.
The extent of tumor resection was based on the sur­
geon’s operative report and the radiologist’s report of the 
immediate postoperative image.
Definition o f Terms
Recurrence was defined as 1) a new area of contrast 
enhancement on the CT scan or MR image at the site of 
the original tumor, 2) radiographic evidence of metastatic 
disease that had not been identified previously, or 3) an 
increase in the size of the primary tumor on CT scans or 
MR images. When the increase in tumor size was minimal 
and equivocal, recurrence was said to have occurred only 
if the patient also had clinical findings consistent with 
recurrence. If the patient had no new symptoms, a diag­
nosis of recurrence was not made until subsequent imag­
ing showed further increase in the tumor size.
Based on the information provided in the clinical rec­
ords and in the radiologist’s reports, CT and MR images 
were divided into categories. They were termed: 1) “post­
operative” if the imaging was done in the early postoper­
ative period to determine the amount of residual tumor 
after surgical intervention; 2) “surveillance” if the imag­
ing was performed for surveillance in the absence of 
symptoms suggestive of tumor recurrence; 3) “nonsur­
veillance,” which included “symptomatic” images, if the 
imaging was performed because of the presence of symp­
toms that created concern about possible recurrence; and 
“asymptomatic” if the imaging was done to determine 
whether there had been a response to a therapeutic inter­
vention, to provide a baseline evaluation following a ther­
apeutic intervention, or to confirm an equivocal finding on 
a previous scan; and 4) “query” if the reason for the imag­
ing was unclear.
When there was no evidence of residual tumor on the 
postoperative image, but an additional image was ob­
tained at the completion of postoperative adjuvant therapy 
(radiotherapy or chemotherapy), the second image was 
categorized as a “surveillance” image. It was rationalized 
that because the postoperative image had shown no resid­
ual tumor, that image provided an adequate baseline; thus 
there was no need to obtain another image after adjuvant 
therapy to determine response to the therapy or to clarify 
a new baseline because it was impossible for the tumor 
to become smaller. If the radiologist’s report of the “post­
operative” image indicated that it was unclear whether 
contrast enhancement represented residual tumor or en­
hancement in the resection margin, for the purpose of cat­
egorizing future images, the image was considered to 
show residual tumor. In this instance an additional image 
scheduled after adjuvant treatment could be categorized as 
a “nonsurveillance” image designed to search for a thera­
peutic response or to establish a new baseline.
For each image, it was determined whether the image 
caused a change in the management of the patient. Such a 
change in management was said to have occurred if the 
image altered previous treatment plans with respect to 
chemotherapy, radiotherapy, or surgery.
An attempt was made to identify all CT and MR images 
obtained to assess the tumor leading up to the time when 
tumor recurrence was identified. Images obtained after the 
diagnosis of tumor recurrence were ignored for the pur­
poses of this study. Images were included in the study if 
they were performed at BCCH or if a report was available 
for imaging performed outside of BCCH. For a minority 
of patients, there may have been some imaging performed 
elsewhere for which no record of the radiologist’s report 
was available in the clinical charts that were reviewed.
Patterns o f Practice
During the period of the study, surveillance images 
were obtained in all children having brain tumors. Except 
in cases of patients who were enrolled in a CCG study 
protocol, there was no standardized protocol establishing 
when the imaging should be performed. However, all 
treating physicians were consistent in their approach to the 
timing of follow-up imaging. For patients with high-grade 
gliomas, PNETs, and ependymomas, images were usually
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Presence o f  residual tumor on postoperative CT or M R image in 




Type of Brain Tumor (no. of cases) No Yes Unclear
supratentorial ganglioglioma (18) 14 3 1
cerebellar astrocytoma (45) 37 4 4
cerebral low-grade astrocytoma (10) 7 2 1
optic/hypothalamic low-grade astrocytoma (11) 0 10 1
thalamic low-grade astrocytoma (5) 1 1 3
cerebellar high-grade glioma (4) 2 1 1
supratentorial high-grade glioma (9) 3 4 2
medulloblastoma/PNET (32) 23 2 7
supratentorial PNET (6) 3 1 2
fourth ventricular ependymoma (19) 13 3 3
totals 103 31 25
* Abbreviations: CT = computerized tomography; MR = magnetic reso­
nance; PNET = primitive neuroectodermal tumor.
obtained at 3 months, 6 months, and 1 year postoperative­
ly, yearly thereafter. For patients with low-grade astrocy­
tomas and gangliogliomas, images were usually obtained 
at 3 months and 1 year postoperatively, yearly thereafter 
for 5 years, and then every 3 to 5 years.
Statistical Analysis
The data were entered into a commercially available 
computer software spreadsheet (Excel; Microsoft Corp., 
Redmond, WA) and analyzed to determine the number 
and type of CT scans and MR images that were obtained, 
the frequency with which surveillance images resulted in 
a change in management, the frequency with which recur­
rences were identified on a surveillance image, and how 
the type of image at which recurrence was identified relat­
ed to outcome after recurrence.
A search of the pediatric neurosurgery database at 
BCCH identified 327 patients with brain tumors, of which 
171 fit the criteria based on histopathological findings and 
location. Of these, 12 patients were excluded: three who 
died within 1 month postoperatively (two cases of medul- 
loblastoma and one of cerebral PNET), and nine for whom 
the records contained inadequate information (three cases 
of cerebellar astrocytoma, two of medulloblastoma, two 
of optic chiasm/hypothalamic astrocytoma, one case each 
of cerebral astrocytoma and cerebral glioblastoma). This 
left 159 patients in the valid study group, composed of 
71 patients with low-grade astrocytoma, the most com­
mon of which was a cerebellar astrocytoma (45 cases), 32 
patients with medulloblastoma/PNET, six with supraten- 
torial PNET, 19 with posterior fossa ependymoma, 18 
with supratentorial ganglioglioma, and 13 patients with 
high-grade glioma (Table 1).
The duration of the follow-up period after surgical biop­
sy or resection for the patients who were alive at their 
last follow-up examination ranged from 2 months to 175 
months, with an average of 67 months and a median of 57 
months. Deaths occurred from 3 to 100 months after sur­
gery, with an average time of 34 months and a median of 
22 months.
Imaging Studies
Early postoperative CT or MR imaging was obtained in 
all patients to provide an assessment of the amount of 
residual tumor after surgical intervention. These images 
were used to determine whether there was a radiographi- 
cally identifiable residual tumor, information important in 
categorizing further follow-up images. Because these 
“postoperative” images did not have the potential to iden­
tify a recurrence, they were excluded from further analy­
ses. In 103 of the 159 cases, no residual tumor was seen 
on the postoperative image; in 31 cases there was definite 
residual tumor; and in the remaining 25 patients it was not 
clear whether enhancement in the resection margin repre-
Results
Population o f Brain Tumors Identified
TABLE 2
Reasons fo r  obtaining follow-up CT and/or MR images in 159 pediatric patients with brain tumor *







Reason for Imaging 
Nonsurveillance
QuerySymptomatic Asymptomatic
supratentorial ganglioglioma 52 49 3 51 1 0 0
cerebellar astrocytoma 214 194 20 192 14 4 4
cerebral low-grade astrocytoma 49 46 3 36 6 3 4
optic/hypothalamic low-grade astrocytoma 48 43 5 27 7 12 2
thalamic low-grade astrocytoma 22 22 0 19 1 2 0
cerebellar high-grade glioma 38 33 5 28 2 8 0
supratentorial high-grade glioma 37 25 12 17 4 14 2
medulloblastoma/PN ET 197 163 34 150 23 14 10
supratentorial PNET 25 25 0 17 5 3 0
fourth ventricular ependymoma 113 89 24 81 12 17 3
totals 795 689 106 618 75 77 25
* Postoperative imaging is not included in this tabulation. Abbreviations: CT = computerized tomography; MR = magnetic reso­
nance; PNET = primitive neuroectodermal tumor.
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TABLE 3
Diagnosis o f  tumor recurrence in 159 pediatric patients 
with brain tumor
Type of Image From Which
Recurrence Was Diagnosed
Surveillance Symptomaticf
Type of Tumor* (no. of cases) (no. of cases)
low-grade tumors (89 cases) 5 10
high-grade tumors (70 cases) 12 17
total 17 27
* Ependymomas are included in the high-grade group.
+ A ll nonsurveillance images at which recurrence was diagnosed were 
obtained to investigate symptoms.
sented residual tumor (Table 1). For the purpose of cate­
gorizing further follow-up images the latter two groups 
were both considered to have residual tumor, forming 
a total of 56 patients in whom follow-up imaging could 
be performed to identify a response to adjuvant treatment 
and/or provide a new baseline.
Excluding the postoperative images, there were 795 fol­
low-up images (689 CT and 106 MR) in the 159 patients. 
Of these images, 618 were surveillance, 152 were non­
surveillance, and 25 were obtained for reasons that were 
not clear. The details of the type of images according to 
the different categories of brain tumor are tabulated in 
Table 2.
Identification o f  Recurrence and Outcome
In the 89 patients with low-grade tumors (that is, gan­
glioglioma and astrocytoma), there were 15 tumor re­
currences, of which 10 were identified on nonsurveillance 
images obtained to investigate symptoms and five on sur­
veillance images (Table 3). The recurrences in the low- 
grade tumors were all at the site of the primary tumor, 
except for one case of a child with a cerebral astrocytoma, 
who experienced recurrence with symptomatic spinal sub­
arachnoid disease and who was also found to have intra­
ventricular ependymal metastases.
In the 70 cases of high-grade tumors (ependymomas 
included in this category) there were 29 recurrences, of 
which 17 were diagnosed on nonsurveillance images ob­
tained to investigate symptoms and 12 on surveillance 
images (Table 3). Four of seven recurrences in patients 
with medulloblastoma/PNET were extracranial metasta­
ses: two of the symptomatic and one of the asymptomatic 
recurrences were metastatic spinal disease, and one symp­
tomatic recurrence was an extraspinal bone metastasis. All 
recurrences of ependymoma were at the site of the pri­
mary tumor, except in the case of one patient in whom 
third ventricular and spinal intradural metastases were 
identified on a surveillance image. For the other malig­
nant tumors, all recurrences were at the primary intracra­
nial site.
The way in which recurrences were identified, the time 
from the original tumor operation to recurrence, the out­
come after diagnosis of recurrence, and the time from the 
original tumor operation to death are detailed in Table 4 
for each of the tumor categories in the study.
Time From Surgery to Diagnosis o f  Recurrence, Last 
Follow-Up Examination, or Death
The relationships between the time from surgical resec­
tion or biopsy to the time of diagnosis of recurrence, the 
time from surgery to the time of death or last follow-up 
examination if alive, and the type of imaging in which 
recurrence was identified were examined, based on the 
information provided in Table 4. For most tumor cate­
gories, the small number of recurrences and the pattern 
of diagnosis of recurrence did not permit a meaningful 
analysis. In cases of optic/hypothalamic astrocytoma, re­
currences tended to be diagnosed earlier after surgery 
when they were diagnosed by a surveillance image than 
by one scheduled in response to symptoms. In the case 
of medulloblastoma and fourth ventricular ependymoma, 
there was no difference in the time from surgery to diag­
nosis of recurrence whether the diagnosis was made on the 
basis of a surveillance or a nonsurveillance symptomatic 
image.
Changes in Patient Management After Imaging
An alteration in care with respect to chemotherapy, 
radiotherapy, or surgery occurred in response to findings 
on 38 of the 795 follow-up images (excluding postopera­
tive images). Of 618 surveillance images, 18 precipitated 
a change in management; these included 17 in which a 
recurrence was diagnosed and one in which a suspected 
recurrence of a cerebral low-grade astrocytoma led to a 
reoperation at which no recurrence was present. An addi­
tional patient was identified as having a recurrence on a 
surveillance image, but it had been decided previously not 
to treat that patient should the tumor recur.
Rates o f  Diagnosis o f  Recurrences per Surveillance Image
The rates of diagnosis of recurrence per surveillance 
image varied according to tumor type (Table 5). For low- 
grade tumors, 27 surveillance images obtained to investi­
gate recurrence of optic hypothalamic astrocytoma diag­
nosed three recurrences for a rate per image of 11.1%, 
whereas the rates of diagnosis per image for supratentori­
al ganglioglioma, cerebellar astrocytoma, cerebral astro­
cytoma, and thalamic astrocytoma ranged from 0% to 2%. 
Among the more common high-grade tumors, medul­
loblastoma had a rate of diagnosis per surveillance image 
of 1.3% of 150 images, and fourth ventricular ependymo­
ma 8.6% of 81 images.
Discussion
The rationale for posttreatment surveillance imaging 
of patients with brain tumors is that the identification of 
asymptomatic recurrences with smaller tumor bulk will 
result in improved outcome with treatment of the recur­
rence. Surveillance imaging for pediatric brain tumors has 
been standard practice, and apparently reasonable surveil­
lance strategies have been developed based on the rate of 
growth of the primary tumor and the pattern of metastatic 
disease.2,3 Whether these strategies result in a significant 
rate of identification of asymptomatic recurrences or, 
more importantly, in an improved outcome for the patient 
has only recently been addressed.1,4
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TABLE 4
Diagnosis o f  tumor recurrence and duration from  operation to recurrence, last follow-up examination, or death*
Patients Who Are Alive Patients Who Died



















Postrecurrence Mos Post-OR 
Average (range) Average (range)
supratentorial ganglioglioma (18)
diagnosed on surveillance image 1 26 1 12 38 0 — —
diagnosed by image for symptoms 0 — 0 — — 0 — —
cerebellar astrocytoma (45)
diagnosed on surveillance image 1 7 1 63 70 0 — —
diagnosed by image for symptoms 1 140 1 142 282 0 — —
cerebral low-grade astrocytoma (10)
diagnosed on surveillance image 0 — 0 — — 0 — —
diagnosed by image for symptoms 4 2 1(12-32) 3 35 (10-70) 57 (34-102) 1 1 18
optic/hypothalamic low-grade astrocytoma (11)
diagnosed on surveillance image 3 6 (2 -1 1 ) 3 52 (4-96) 5 8(6 -1 0 6 ) 0 — —
diagnosed by image for symptoms 4 26 (9-37) 2 22 (5-40) 54 (32-76) 2 3 0(14-46) 49 (22-76)
thalamic low-grade astrocytoma (5)
diagnosed on surveillance image 0 — 0 — — 0 — —
diagnosed by image for symptoms 1 2 0 — — 1 1 3
cerebellar high-grade glioma (4)
diagnosed on surveillance image 0 — 0 — — 0 — —
diagnosed by image for symptoms 2 55 (13-98) 0 — — 2 4 (2 -5 ) 59 (18-100)
supratentorial high-grade glioma (9)
diagnosed on surveillance image 1 14 1 15 30 0 — —
diagnosed by image for symptoms 4 10 (3-16) 0 — — 4 8 (5-11) 18 (9-28)
medulloblastoma/PNET (32)
diagnosed on surveillance image 2 12 (5-20) 2 63 (9-118) 75 (28-123) 0 — —
diagnosed by image for symptoms 5 14 (5-25) 1 84 102 4 2 (0 -5 ) 15 (8-26)
supratentorial PNET (6)
diagnosed on surveillance image 2 3 8(21-55) 1 50 105 1 12 35
diagnosed by image for symptoms 2 6 (5-6) 0 — — 2 4 (3-6) 10 (8-12)
fourth ventricular ependymoma (19)
diagnosed on surveillance image 7 33 (4-52) 3 42 (7-62) 74 (51-111) 4 33 (19-70) 66 (45-99)
diagnosed by image for symptoms 4 35 (21-57) 0 — — 4 20 (5-35) 55 (31-87)
* Abbreviations: OR = initial surgical resection or biopsy for tumor; PNET = primitive neuroectodermal tumor; —  = not applicable.
Rates o f Identification o f  Asymptomatic Recurrences
In this series of 159 children with a variety of brain tu­
mors, 17 (39%) of 44 recurrences were diagnosed on 
the basis of a surveillance image, whereas the majority of 
recurrences were identified from findings on an image 
obtained in response to a change in symptoms. The per­
centage of recurrences that were asymptomatic at diagno­
sis was not homogeneous among the different categories 
of tumors. The fourth ventricular ependymoma stood out 
as the single tumor in which the majority of recurrences 
(64%) were diagnosed using a surveillance image. In the 
supratentorial PNET and optic/hypothalamic low-grade 
astrocytoma, approximately half of the recurrences were 
picked up on surveillance imaging; in the remainder of the 
tumors, 23% were diagnosed while the patients were 
asymptomatic. There have been three previous studies that 
addressed the frequency with which asymptomatic recur­
rences of pediatric brain tumors were identified. In 1993, 
Elterman and Bruce1 reported that 13 (62%) of 21 recur­
rences of medulloblastoma were asymptomatic at detec­
tion. On the other hand, in the 1994 study by Torres and 
colleagues4 four asymptomatic recurrent medulloblasto- 
mas (17%) were detected among 23 recurrences; this was 
similar to our series in which two (29%) of seven re­
current medulloblastomas were asymptomatic at diagno­
sis. In a study of cerebellar astrocytomas undertaken by 
Sutton and associates (LN Sutton, personal communica­
tion, 1995), 11 asymptomatic recurrences were identified 
among 17 recurrences in 93 patients.
Relationship Between Identification o f  Asymptomatic 
Recurrence and Outcome
There was a suggestion of improved outcome with 
asymptomatic diagnosis of recurrence in patients with ma­
lignant tumors. This was most apparent in the cases of 
fourth ventricular ependymomas in which all four patients 
with symptomatic recurrences died, but three of seven 
with asymptomatic recurrences survived until the most 
recent follow-up examination. It should be noted, howev­
er, that the follow-up period in these cases was relatively 
short. For the low-grade tumors, a possible outcome ad­
vantage was seen only in patients with optic/hypothalam­
ic tumors. Tumor recurrences were rare in patients with 
the most benign tumors, namely cerebellar astrocytomas 
(two recurrences in 45 cases) and supratentorial gan- 
gliogliomas (one recurrence in 18 cases), and all three pa­
tients were alive after treatment of their recurrence. Al­
though two of the recurrences were asymptomatic, the 
outcome may have been the same if treatment, namely 
repeat resection, was withheld until the recurrence caused 
symptoms.
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TABLE 5
Diagnosis o f  asymptomatic tumor recurrence by sun ’eillance 
imaging in 159 pediatric patients with brain tumor
No. of Asymp­
No. of tomatic Tumor Rate of
Surveillance Recurrences Diagnosis*
Type of Tumor Images Identified (%)
supratentorial ganglioglioma 51 1 2.0
cerebellar astrocytoma 192 1 0.5
cerebral low-grade astrocytoma 36 0 0.0
optic/hypothalamic low-grade 27 3 11.1
astrocytoma
thalamic low-grade astrocytoma 19 0 0.0
cerebellar high-grade glioma 28 0 0.0
supratentorial high-grade glioma 17 1 5.9
medulloblastoma/PNETt 150 2 1.3
supratentorial PNET 17 2 11.8
fourth ventricular ependymoma 81 7 8.6
totals 618 17 2.8
* The rate o f diagnosis indicates the percentage of surveillance images 
that resulted in a diagnosis o f recurrence, 
t  PNET = primitive neuroectodermal tumor.
Possible Negative Consequences o f Smveillance Imaging
The benefits of diagnosis of asymptomatic recurrences 
must be weighed against the possible negative conse­
quences of multiple surveillance images that are required. 
There may be morbidity associated with the sedation of 
a young child and anxiety to the patient and/or family 
associated with each imaging appointment, which is a re­
minder of the potential for recurrence of tumor. Imaging 
can be costly, and where there is a high demand for ser­
vices, surveillance imaging may compete for scarce imag­
ing time. In the 159 patients in this series, 618 surveillance 
images were documented, from these 17 asymptomatic re­
currences were diagnosed, for a 2.8% rate of diagnosis of 
recurrence per image. The rate of diagnosis of recurrence 
per surveillance image varied according to tumor type, 
from 0% to 11.8% (Table 5).
Optimizing Smveillance Imaging Regimens
One possible explanation for the low rate of diagnosis 
of asymptomatic recurrences by surveillance imaging in 
this and other series may be that the timing of surveillance 
imaging was not optimal for detecting recurrence. The 
surveillance regimens that were used during the period of 
the study were either those specified by a CCG protocol 
for those children entered into a CCG study, or a nonstan­
dardized, although fairly consistent, protocol based on the 
perceived malignancy of the tumor. These surveillance 
regimens may seem reasonable, but like other surveillance 
recommendations,2 they are not based on specific data 
concerning the pattern and time to recurrence, and, as 
such, the yield per surveillance image may not have been 
optimal. To optimize the identification of asymptomatic 
recurrence, one might tailor the timing of surveillance 
imaging according to the actual patterns of recurrence 
of the individual tumor. Life table analysis of the time 
to recurrence for the three most common types of tumor 
in this study shows a striking difference in the pattern 
of the time to recurrence between cerebellar astrocyto-
Optimal Surveillance Scanning Intervals
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Fig. I. Graph of Kaplan-Mcicrplots illustrating the time to rc- 
currcncc for ccrcbcllar astrocytoma, fourth ventricular ependymo­
ma, and mcdulloblastoma/primitivc ncurocctodcrmal tumor. The 
postrcscction time periods during which survcillancc images have 
the highest chance of detecting recurrence arc shown for ependy­
momas and mcdulloblastomas.
ma, medulloblastoma/PNET, and ependymoma (Fig. 1). A 
rational scheme for the timing of surveillance imaging 
could be designed according to tumor-specific patterns of 
recurrence accounting for the time to recurrence and the 
subsequent rate of recurrence, as follows: for cerebellar 
astrocytomas, no surveillance imaging; for medulloblas- 
toma/PNETs, multiple (perhaps every 3 months) surveil­
lance imaging in the first 2 1/2 years and none thereafter; 
and for fourth ventricular ependymomas, no surveillance 
imaging until 18 months after resection, followed by mul­
tiple imaging (every 4 -6  months) for the next 3 1/2 years, 
and no imaging thereafter.
In addition to the timing of surveillance imaging, we 
also need to determine whether it is appropriate to inves­
tigate only the brain, or whether we should also examine 
the spine to identify metastatic disease. This should be 
based on the expected rate of spinal metastasis for any tu­
mor type. In the current study, recurrence as spinal meta­
static disease occurred significantly only in medulloblas­
toma/PNET, and thus we suggest that surveillance might 
reasonably include spinal MR imaging for medulloblas­
toma/PNET, but not for the other types of tumors studied.
Conclusions
We conclude that the value of surveillance imaging af­
ter treatment of pediatric brain tumors varies according to 
the type of tumor. Our data indicate that a surveillance 
imaging protocol such as the one described in this study is 
not required in cases of supratentorial ganglioglioma or 
cerebellar astrocytoma during follow-up intervals equiva­
lent to those specified in this study, namely an average of 
37 months for ganglioglioma and 82 months for cerebel­
lar astrocytoma. Recurrence is unusual if the tumor has 
been resected completely, and therefore the rate of diag­
nosis of an asymptomatic recurrence per surveillance im­
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age is very low. It may be argued that if there is residual 
disease, surveillance imaging may be appropriate because 
the risk of recurrence is increased (LN Sutton, personal 
communication, 1995). However, if the tumor recurs, it is 
probable that a favorable outcome will be achieved with 
resection of the recurrence, regardless of the tumor size, 
and thus early detection of recurrences when the patient is 
asymptomatic may not necessarily improve outcome.
We would recommend that surveillance imaging be 
performed in children with fourth ventricular ependymo­
mas, because the majority of recurrences were identified 
on surveillance images, and outcome seemed to be better 
when the recurrence was identified prior to symptoms. 
Until further data are available we would also advocate 
surveillance imaging for patients with optic/hypothalamic 
astrocytomas because almost half of the recurrences were 
asymptomatic at diagnosis, and for medulloblastoma be­
cause the patients who were asymptomatic at detection of 
recurrence may have had a more favorable outcome.
Our conclusions about the value of surveillance imag­
ing are based on the regimens for surveillance used in our 
institution during the period of the study, and on data 
spanning a 12-year period, during which the majority of 
images obtained were CT scans. In retrospect, these sur­
veillance imaging regimens were probably not optimal. 
By individualizing surveillance protocols for each type of 
brain tumor, based on up-to-date data concerning the pat­
terns of recurrence, it should be possible to increase the 
cost effectiveness of surveillance imaging, which might 
lead to different conclusions. It is also possible that MR 
imaging might detect recurrences earlier, and that as more 
effective therapies for recurrent disease become available,
better outcomes may occur in patients whose recurrences 
are identified at an early stage. Our conclusions with 
respect to cerebellar astrocytomas and cerebral ganglio­
glioma will probably not be affected by such develop­
ments; however, for the other tumors it is important that 
there are ongoing prospective studies of the value of sur­
veillance strategies, with reevaluation as technological 
and therapeutic advances occur.
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